Current evidence suggests these are long-term treatments, similar to blood pressure or cholesterol medications
Key Points Levels of glutathione within the cells and mitochondria are highly associated with health and longevity, and its deficiency is associated with loss of function with aging and many chronic diseases (including depression, anxiety, Alzheimers, Parkinsons, heart disease, and even cancer) Research over the last several years has illustrated a positive relationship between glutathione and vitamin D, with higher vitamin D levels related to higher glutathione levels
Human clinical research remains early stage, with small pilot studies exploring its effects on exercise performance, insulin sensitivity, and metabolic biomarkers rather than obesity endpoints
Willingness to Take Cases to Trial Trial capability separates attorneys who can credibly threaten litigation from those who must accept whatever settlement defendants offer, directly impacting the compensation clients ultimately receive in pharmaceutical mass tort cases
Results should be considered with standard cardiovascular markers, medical history, and clinical evaluation
Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist T2DM: Type-2 diabetes mellitus DPP-4: Dipeptidyl peptidase 4 HbA1c: Hemoglobin A1c NASH: Non-alcoholic steatohepatitis NAFLD: Non-alcoholic fatty liver disease Camp: Cyclic adenosine monophosphate PKA: Protein kinase A EPAC: Exchange protein directly activated by cAMP PI3K: Phosphoinositide 3-kinase PYY: Peptide YY CCK: Cholecystokinin GLUT4: Glucose transporter type 4 mTORC1: Mammalian target of rapamycin complex 1 References Ahrn B (2015) Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes